{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:02:31Z","timestamp":1790906551006,"version":"4.1.0"},"reference-count":16,"publisher":"Galenos Yayinevi","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Phys Med Rehab"],"accepted":{"date-parts":[[2019,12,27]]},"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:p>Infliximab is an inhibitory of tumor necrosis factor-alpha which is used successfully for the treatment of inflammatory bowel disease and rheumatic disease. It has various side effects including injection-induced reactions, immunosuppression, demyelinating diseases, and cardiac effects. One of the most serious side effects is tuberculosis. In particular, the immunosuppressant drugs have a high risk of reactivating latent tuberculosis infection. Its activation probably may occur as an extra-pulmonary and, occasionally, may result in an unusual infection. Herein, we report a 30-year-old male case treated with infliximab and suffered from isolated testicular tuberculosis.<\/jats:p>","DOI":"10.5606\/tftrd.2021.5135","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T05:17:14Z","timestamp":1641532634000},"page":"374-377","source":"Crossref","is-referenced-by-count":3,"title":["A rare localization of tuberculosis under infliximab treatment: Testicular involvement"],"prefix":"10.4274","volume":"67","author":[{"given":"Mehmet","family":"Nay\u0131mo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Sar\u0131fak\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fcbra","family":"Usta\u00f6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015feg\u00fcl","family":"Isal Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Keane J. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford) 2005;44:714-20.","DOI":"10.1093\/rheumatology\/keh567"},{"key":"ref-2","unstructured":"Beenhouwer D, Wallis R, Broder M, Furst DE. Mechanisms of action of tumor necrosis factor antagonist and granulomatous infections. J Rheumatol 2004;31:1888-92."},{"key":"ref-3","unstructured":"PAY S. Romatizmal Hastal\u0131klarda Anti-TNF ila\u00e7 kullan\u0131m\u0131. T\u00fcrkiye Klinikleri T\u0131p Bilimleri Dergisi 2006;26:430-40."},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Drudi FM, Laghi A, Iannicelli E, Di Nardo R, Occhiato R, Poggi R, et al. Tubercular epididymitis and orchitis: US patterns. Eur Radiol 1997;7:1076-8.","DOI":"10.1007\/s003300050257"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Wallis RS, Ehlers S. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 2005;34(5 Suppl1):34-8.","DOI":"10.1016\/j.semarthrit.2005.01.009"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Scheinfeld N. A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 2004;15:280-94.","DOI":"10.1080\/09546630410017275"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Wallis RS, Broder M, Wong J, Beenhouwer D. Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis 2004;39:1254-5.","DOI":"10.1086\/424455"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Hane J, Duffey B, Kaiser R, Walker PF, Alpern JD. Case report: Epididymo-orchitis due to mycobacterium tuberculosis. Am J Trop Med Hyg 2019;101:1070-2.","DOI":"10.4269\/ajtmh.19-0162"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Agbodande AK, Dodo RL, Issa A, Adjadohoun S, Azon- Kouanou A, Wanvoegbe AF, et al. Rare location of tuberculosis: endometrial tuberculosis. Pan Afr Med J 2019;33:45.","DOI":"10.11604\/pamj.2019.33.45.17520"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Garbyal RS, Gupta P, Kumar S; Anshu. Diagnosis of isolated tuberculous orchitis by fine-needle aspiration cytology. Diagn Cytopathol 2006;34:698-700.","DOI":"10.1002\/dc.20538"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Shugaba AI, Rabiu AM, Uzokwe C, Matthew RM. Tuberculosis of the testis: a case report. Clin Med Insights Case Rep 2012;5:169-72.","DOI":"10.4137\/CCRep.S9451"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Salvador R, Vilana R, Bargall\u00f3 X, Araque X, Nicolau C. Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings. J Ultrasound Med 2007;26:671-4.","DOI":"10.7863\/jum.2007.26.5.671"},{"key":"ref-13","unstructured":"Viswaroop BS, Kekre N, Gopalakrishnan G. Isolated tuberculous epididymitis: a review of forty cases. J Postgrad Med 2005;51:109-11."},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Beacock CJ, Lynch TH, Hughes MA. Fatal tuberculous meningitis complicating tuberculous epididymitis. Br J Urol 1991;67:328-9.","DOI":"10.1111\/j.1464-410X.1991.tb15149.x"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Wise GJ, Shteynshlyuger A. An update on lower urinary tract tuberculosis. Curr Urol Rep 2008;9:305-13.","DOI":"10.1007\/s11934-008-0053-9"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH. Tuberculosis in patients with end-stage renal disease. Am J Med 1980;68:59-65.","DOI":"10.1016\/0002-9343(80)90166-7"}],"container-title":["Turkish Journal of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:07:54Z","timestamp":1783066074000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4305.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.5606\/tftrd.2021.5135","relation":{},"ISSN":["2587-1250"],"issn-type":[{"value":"2587-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}